Physician

Babak Sanei Fard, M.D.

According to 2025 Medicare claims, Babak Fard, M.D. (NPI: 1225199805) practices interventional cardiology in the Yuba City, CA market, with the plurality of this provider's patient population coming from Sutter, CA. This provider's primary affiliated billing organization is ADVENTIST HEALTH PHYSICIANS NETWORK (NPI: 1104324102; TIN: 680357690) and primary practice location at 95901-5669. Fard is affiliated with the Adventist Health Accountable Care, LLC (ACO ID: A3873), participating under the MSSP model.

Fard's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,158 traditional Medicare patients, billed 5,172 HCPCS/CPT codes, and received $298,958 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,744 prescription claims across 588 beneficiaries totaling $967,825 in drug costs, led by Eliquis (Apixaban). 2020 DME data shows 13 claims. Open Payments data shows 9 records totaling $509. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $96,711 to $967,825. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	763	2,830	$182,256
2016	955	3,484	$219,597
2017	938	3,473	$218,220
2018	1,080	3,621	$226,892
2019	1,043	3,233	$215,281
2020	789	2,632	$192,100
2021	881	2,980	$232,056
2022	1,241	3,686	$263,193
2023	1,150	3,697	$260,323
2024	1,158	5,172	$298,958

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	216	2,181	$96,711
2016	243	2,737	$132,937
2017	296	3,751	$210,853
2018	307	4,342	$263,079
2019	363	4,738	$353,528
2020	349	2,990	$276,662
2021	319	2,754	$270,583
2022	413	3,583	$528,644
2023	498	5,106	$761,062
2024	588	6,744	$967,825

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	12	$23,869
2020	N/R	13	$24,985
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	521	1,316	$98
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	507	535	$53
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	552	1,493	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	162	172	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	286	351	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	287	15,667	$309,711
Entresto	Sacubitril/Valsartan	185	8,040	$174,054
Jardiance	Empagliflozin	150	7,020	$132,666
Xarelto	Rivaroxaban	76	4,630	$84,488
Repatha Sureclick	Evolocumab	74	3,344	$64,561

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$509	ABIOMED
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Babak Sanei Fard, M.D.?

Tedicare shows public-source Medicare data for Babak Sanei Fard, M.D. (NPI 1225199805), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Babak Sanei Fard, M.D. have ACO affiliation data?

Babak Sanei Fard, M.D. is shown with ACO affiliation data for Adventist Health Accountable Care, LLC (MSSP, ACO ID A3873).

What billing organization is linked to Babak Sanei Fard, M.D.?

Babak Sanei Fard, M.D. is linked to ADVENTIST HEALTH PHYSICIANS NETWORK (billing NPI 1104324102) in the available physician profile data.

Does Babak Sanei Fard, M.D. have Open Payments data?

Babak Sanei Fard, M.D. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.